Skip to main content
OpenTrials

Clinical trial condition

Metastatic Melanoma

Explore clinical trials studying Metastatic Melanoma. Study availability and eligibility vary by location and protocol.

228 public trials 41 recruiting studies
Refine in advanced search Browse all conditions

Metastatic Melanoma trial results

Completed

Uprosertib, Dabrafenib, and Trametinib in Treating Patients With Stage IIIC-IV Cancer

NCT01902173

Conditions
Hematologic Diseases, Hematologic Neoplasms, Hematopoietic and Lymphoid Cell Neoplasm, +25 more
Locations
  • USC / Norris Comprehensive Cancer Center Los Angeles, California, United States
  • UCLA / Jonsson Comprehensive Cancer Center Los Angeles, California, United States
  • California Pacific Medical Center-Pacific Campus San Francisco, California, United States
  • UCSF Medical Center-Mount Zion San Francisco, California, United States
View all 16 locations
View Trial Details
Completed

Radiotherapy & Combi in Metastatic Melanoma

NCT02392871

Conditions
Melanoma, Metastatic Melanoma, Neoplasms, +10 more
Locations
  • St Vincent's Hospital Darlinghurst, New South Wales, Australia
  • Westmead Hospital Sydney, New South Wales, Australia
  • Princess Alexandra Hospital Brisbane, Queensland, Australia
View Trial Details
Completed

A Study to Evaluate Safety and Therapeutic Activity of RO6874281 in Combination with Pembrolizumab, in Participants with Advanced or Metastatic Melanoma

NCT03875079

Conditions
Melanoma, Metastatic Melanoma, Neoplasms, +10 more
Locations
  • Yale University New Haven, Connecticut, United States
  • University of Iowa Iowa City, Iowa, United States
  • Beth Israel Deaconess Med Ctr Boston, Massachusetts, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
View all 23 locations
View Trial Details
Completed

Pharmacokinetic Drug-drug Interaction Study of Encorafenib and Binimetinib on Probe Drugs in Patients With BRAF V600-mutant Melanoma or Other Advanced Solid Tumors

NCT03864042

Conditions
Advanced Solid Tumors, Melanoma, Metastatic Melanoma, +11 more
Locations
  • UC Irvine Health Orange, California, United States
  • University of Colorado Hospital - Anschutz Cancer Pavilion (ACP) Aurora, Colorado, United States
  • University of Illinois at Chicago Chicago, Illinois, United States
  • Hopkins Eye Clinic Hopkins, Minnesota, United States
View all 29 locations
View Trial Details
Completed

A Randomized, Controlled, Multi-center, Phase III Clinical Study to Investigate Recombinant Humanized PD-1 Monoclonal Antibody Injection (JS001) Versus Dacarbazine as the 1st-line Therapy for Unresectable or Metastatic Melanoma

NCT03430297

Conditions
Melanoma, Metastatic Melanoma, Neoplasms, +11 more
Locations
  • Hefei Binhu Hospital Hefei, Anhui, China
  • Beijing Cancer Hospital Beijing, Beijing Municipality, China
  • Fujian Cancer Hospital Fuzhou, Fujian, China
  • Sun Yat-sen University Cancer Center Guangzhou, Guangdong, China
View Trial Details

Related conditions